Persistent Asset Partners »

Immix Biopharma shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $166k 32k 5.23

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Immix Biopharma

Saturn V Capital Management
Eventide Asset Management
Marshall Wace
Vanguard Group
Logos Global Management
Bleichroeder
Blue Owl Capital Holdings
Franklin Resources
Susquehanna International
Ameriprise Financial
Burkehill Global Management
Renaissance Technologies
Geode Capital Management
KVP Capital Advisors
Goldman Sachs Group

View all funds holding Immix Biopharma